Skip to Main Content

The (POGO) Blog

August 12, 2016

By David S. Hilzenrath

UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO



Picture of a drop of blood on thumb. Alere Inc., maker of faulty INRatio blood testing devices, said it has received a Justice Department subpoena for records related to the devices’ accuracy and “interactions with the FDA.”

Continue Reading UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO

Topics: Government Accountability, Public Health and Science

July 13, 2016

By David S. Hilzenrath

FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss



Picture of a drop of blood on thumb. The FDA said faulty INRatio blood testing devices had “minimal” impact on a clinical trial of blood thinner Xarelto that FDA head Robert Califf co-chaired.

Continue Reading FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss

Topics: Government Accountability, Public Health and Science

July 13, 2016

By David S. Hilzenrath

Faulty Blood Testing Devices to Be Withdrawn from Market



Photograph of a finger prick with blood drop Alere, maker of INRatio blood testing devices whose potentially fatal flaws POGO spotlighted, said it is taking the machines off the market.

Continue Reading Faulty Blood Testing Devices to Be Withdrawn from Market

Topics: Government Accountability, Public Health and Science

April 22, 2016

By Danielle Brian

POGO Wins National Journalism Prize for Reporting on FDA



Emergency Room Gurney 120 The Society of Professional Journalists has awarded the Project On Government Oversight a Sigma Delta Chi Award for POGO’s coverage of potentially deadly weaknesses in FDA oversight of prescription drugs.

Continue Reading POGO Wins National Journalism Prize for Reporting on FDA

Topics: Government Accountability, Public Health and Science

February 12, 2013

By Andre Francisco

POGO's Staff Scientist Says New Doctor Rules Promote Transparency



Drug and FDA Issues New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, POGO's staff scientist.

Continue Reading POGO's Staff Scientist Says New Doctor Rules Promote Transparency

Topics: Public Health and Science

Items 1 - 5 of 6  12Next

Browse POGOBlog by Topic

POGO on Facebook

Latest Podcast

Fly Before You Buy: Tom Christie on Realistic Combat Testing

The Project On Government Oversight's Dan Grazier recently sat down with Tom Christie, a former Director of Operational Test & Evaluation at the DoD from 2001-2005, to talk about the critical need for realistic combat testing before the Pentagon buys new weapons.